The RASGRP3, a RAS activator is known to play a role in several cancers, including breast (Nagy et al., 2014), papillary thyroid (Qiu et al., 2017), and prostate cancers (Yang et al., 2010). Here, RASGRP3 is linked to Familial prostate cancer.